-
Clinical trial of multi-vaccine regimen targets advanced cancer
-
New trial evaluates investigational drug for endometrial and breast cancers
-
Selumetinib granted orphan status for NF1 treatment
-
Immunotherapy trial for prostate cancer patients
-
Activated platelets can promote tumor cell invasion into healthy tissue
-
RT @HSaterMD: Just got to @theNCI @NCIResearchCtr to find a great vibe of #energy and #happiness brought up by employees’ #kids v… https://t.co/MZcKTqrm4F
-
RT @sowalsky: Hot or not? Haydn Kissick delivers the @theNCI GU Malignancies Center of Excellence seminar about the immune niche… https://t.co/4WuP6bcFGN
-
RT @gulleyj1: Delighted that the brilliant Haydn Kissick is giving the GU Center of Excellence lecture today on the #immunologic… https://t.co/6Wl7WtZSk9
-
Today we welcome Dr. Kissick @WinshipAtEmory to discuss #immunology and urologic cancers at our GU Malignancies Sem… https://t.co/eC0nGfL2xp
-
RT @NCIBillDahut: It’s another wonderful Take Your Child to Work Day at the NCI! https://t.co/v8DqcqLbBD
-
RT @CRForumUS: Dr. Nirali Shah @NCIResearchCtr with her poster and award for her work in finding alternative treatment for leukemi… https://t.co/cIBlsNcIUt
-
RT @Dr_RaviMadan: Asian J Andrology Issue on #ProstateCancer #chemotherapy #BoneTargeting #biomarkers #PPARγ #VitD #immunotherapy Aut… https://t.co/eaXAYsYDp5
